Pet Pharm Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	268.65	181.79	168.49	16.76
Short-Term Investments	250.21	206.14	-	-
Cash & Short-Term Investments	518.86	387.93	168.49	16.76
Cash Growth	33.75%	130.25%	905.52%	-
Receivables	59.35	33.78	31.24	20.91
Inventory	14.64	13.68	10.8	5.81
Prepaid Expenses	2.06	2.12	2.61	-
Other Current Assets	5.64	4.43	141.28	54.84
Total Current Assets	600.55	441.93	354.4	98.31
Property, Plant & Equipment	395.06	290.2	92.45	84.57
Goodwill	8.24	-	-	-
Other Intangible Assets	85.09	9.08	4.05	5.08
Long-Term Deferred Tax Assets	2.83	2.09	-	-
Other Long-Term Assets	255.27	16.76	36.67	3.93
Total Assets	1,347	760.06	487.58	191.89
Accounts Payable	3.1	7.92	4.81	2.91
Current Portion of Long-Term Debt	0.42	100	-	-
Current Portion of Leases	11.19	6.42	6.57	4.58
Current Income Taxes Payable	0.02	-	-	-
Current Unearned Revenue	4.81	4.31	3.94	3.09
Other Current Liabilities	36.72	21.41	16.99	8.88
Total Current Liabilities	56.25	140.05	32.31	19.46
Long-Term Debt	17.34	-	-	-
Long-Term Leases	77.22	37.46	41.63	37.94
Long-Term Deferred Tax Liabilities	0	-	-	-
Other Long-Term Liabilities	0.55	-	-	-
Total Liabilities	151.36	177.52	73.94	57.4
Common Stock	572.33	405.29	371.9	251.9
Additional Paid-In Capital	574.88	78.72	150.01	-
Retained Earnings	26.86	14.51	-108.27	-117.42
Comprehensive Income & Other	-	84.03	-	-
Total Common Equity	1,174	582.54	413.64	134.48
Minority Interest	21.63	-	-	-
Shareholders' Equity	1,196	582.54	413.64	134.48
Total Liabilities & Equity	1,347	760.06	487.58	191.89
Total Debt	106.16	143.88	48.2	42.52
Net Cash (Debt)	412.7	244.05	120.29	-25.77
Net Cash Growth	69.11%	102.89%	-	-
Net Cash Per Share	7.65	5.98	4.05	-1.07
Filing Date Shares Outstanding	57.23	41.07	29.73	24.13
Total Common Shares Outstanding	57.23	41.07	29.73	24.13
Working Capital	544.3	301.88	322.1	78.85
Book Value Per Share	20.51	14.18	13.92	5.57
Tangible Book Value	1,081	573.47	409.59	129.4
Tangible Book Value Per Share	18.88	13.96	13.78	5.36
Land	172.41	172.41	-	-
Machinery	147.9	93.4	80.44	-
Construction In Progress	11.16	14.59	-	-
Leasehold Improvements	73.48	51.47	39.47	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.